IDO1 and medullary breast carcinoma: However, Jacquemier et al. reported an opposite effect of IDO in medullary breast cancer (MBC), a subtype of basal-like breast cancer different from invasive carcinoma, in which high expression of IDO in stromal or epithelial cells was associated with large amount of lympoid infiltrate and a favorable clinical outcome of patients [40].